November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 20, 2026
According to market projections, the fermenters and bioreactors sector is expected to grow from USD 22.42 billion in 2025 to USD 60.52 billion by 2035, reflecting a CAGR of 10.44%. The growing demand for biologics and advancements in manufacturing technology drive the market. North America led the global market, owing to technological advancements ...
January 20, 2026
According to market projections, the global novel spectrometry market, valued at USD 4.18 billion in 2025, is anticipated to reach USD 23.35 billion by 2035, growing at a CAGR of 18.77% over the next decade. Advancements in technology and growing research and development activities drive the market. North America dominated the global market due to ...
January 20, 2026
According to our projections, the U.S. cell and gene therapy clinical trials market was valued at USD 5.41 billion in 2025 and is projected to grow from USD 6.26 billion in 2026 to USD 23.14 billion by 2035, registering a CAGR of 15.64% during 2026 to 2035....
January 20, 2026
According to our forecasts, the medical engineered materials market was valued at USD 32.95 billion in 2026 and is projected to reach approximately USD 99.3 billion by 2035, expanding at a CAGR of 13.04% during 2026–2035....
January 20, 2026
Based on our market forecasts, the drug delivery devices market was valued at USD 463.86 billion in 2025 and is projected to reach USD 500.23 billion in 2026, expanding further to approximately USD 986.7 billion by 2035 at a CAGR of 7.84% from 2026 to 2035....
January 20, 2026
Our projections indicate that, the Ayurveda market was valued at USD 20.45 billion in 2025 and is estimated to reach USD 24.49 billion in 2026, expanding significantly to USD 124.01 billion by 2035, registering a strong CAGR of 19.75% during 2026 to 2035....
January 19, 2026
According to forecasts, the global asthma and COPD drugs market will grow to USD 70.27 billion by 2035, with an expected CAGR of 5.01%. In 2024, King's College London showed that benralizumab can reduce hospitalizations in severe asthma and treat asthma and COPD. Boehringer Ingelheim launched a $35/month inhaler program for uninsured or high-copay ...
January 19, 2026
Forecasts suggest that the cell and gene therapy market will expand USD 232.22 billion by 2035, with a CAGR of 24% during the forecasted period. Gene therapy is rapidly evolving, driven by CRISPR and CAR-T advancements. Once focused on rare diseases and cancer, it now targets neurological, cardiovascular, and autoimmune conditions. With fast-tracke...
January 19, 2026
According to market projections, the diabetes drugs sector is expected to grow from USD 75.16 billion in 2025 to USD 143.76 billion by 2035, reflecting a CAGR of 6.7%. The diabetes drugs market is growing due to the rising global prevalence of diabetes, with over 537 million adults affected. Factors driving this growth include increased R&D, go...
January 19, 2026
According to market projections, the cell therapy sector is expected to grow from USD 7.21 billion in 2025 to USD 55.72 billion by 2035, reflecting a CAGR of 22.69%. The focus on developing therapeutics for rare diseases is driving the market growth....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com